In addition, biomarkers such as RAS mutation, BRAF mutation, and PD-L1 expression are actively being investigated in relation to treatment options and prognosis in many gastrointestinal cancers, including colorectal cancer [40,41,42]. Here, BRAF is linked to colorectal cancer.